Reach Neuro

Reach Neuro is pioneering a novel therapeutic intervention for chronic post-stroke motor disability, a condition with no approved restorative treatments. The company's core technology involves an implanted electrode array and pulse generator that delivers targeted electrical stimulation to specific cervical spinal cord segments to reactivate neural circuits controlling arm and hand function. As a private, pre-revenue startup, Reach Neuro is in the pre-clinical or early clinical development stage, aiming to address a significant unmet need in neurorehabilitation. The founding team combines expertise in neuroscience, biomedical engineering, and neurosurgery.

Implantable epidural spinal cord stimulation system with a cervical electrode array and pulse generator. Delivers personalized electrical stimulation to specific spinal segments (C5-C8) to reactivate neural circuits and restore volitional control of shoulder, arm, and hand movement.

Direct competitors offering implantable restorative therapy for chronic stroke are scarce. The competitive landscape includes alternative approaches such as non-invasive brain stimulation (e.g., transcranial magnetic stimulation), advanced robotic rehabilitation devices, and brain-computer interfaces (BCIs). Established spinal cord stimulator companies (e.g., Medtronic, Boston Scientific) focus on pain, not motor restoration.